| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028279 |
| Receipt No. | R000032372 |
| Scientific Title | A follow-up study to evaluate the infant skin condition in summer |
| Date of disclosure of the study information | 2017/08/10 |
| Last modified on | 2021/01/19 (Ver. 5) |
| Basic information | ||
| Public title | A follow-up study to evaluate the infant skin condition in summer | |
| Acronym | A study to evaluate the infant skin condition | |
| Scientific Title | A follow-up study to evaluate the infant skin condition in summer | |
| Scientific Title:Acronym | A study to evaluate the infant skin condition | |
| Region |
|
|
| Condition | |||
| Condition | Healthy infants | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Understandings of skin condition |
| Basic objectives2 | Others |
| Basic objectives -Others | Observational Study |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Measurement of infant skin condition |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy infants | |||
| Key exclusion criteria | 1. Infant with chronic sickness.
2. Infant with the severe skin symptoms who needs treatment of an atopic dermatitis et al. 3. The infant infected with a disease of infectibility disease. 4. The infant who judged that a test doctor in attendance was unsuitable as a test participant. |
|||
| Target sample size | 80 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kao Corporation | ||||||
| Division name | R&D - Development Research - Sanitary Products Research | ||||||
| Zip code | 321-3497 | ||||||
| Address | 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN | ||||||
| TEL | 0285-68-7432 | ||||||
| okuda.yasuyuki@kao.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kao Corporation | ||||||
| Division name | R&D - Development Research - Sanitary Products Research | ||||||
| Zip code | 321-3497 | ||||||
| Address | 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN | ||||||
| TEL | 0285-68-7379 | ||||||
| Homepage URL | |||||||
| kajiwara.jun@kao.co.jp | |||||||
| Sponsor | |
| Institute | Kao Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Human Research Ethics Committee, Kao Corporation |
| Address | 2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN |
| Tel | +81-3-5630-9220 |
| uesaka.toshio@kao.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | DRC株式会社(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Measurement of infant skin condition |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032372 |